# Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia

> **NCT06225128** · — · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 120 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **OTHER:** Biobanking blood
- **OTHER:** Bone marrow specimens

## Key facts

- **NCT ID:** NCT06225128
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-16
- **Primary completion:** 2027-06-19
- **Final completion:** 2027-06-19
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06225128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06225128, "Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06225128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*